authors
- Rosenbaum, Cara
- Özbek, Umut
- Sanchez, Larysa
- Lagdameo, Jonathan
- Abrahams, Alex
- Hassoun, Hani
- Lahoud, Oscar
- Niesvizky, Ruben
- Landau, Heather J
- Osman, Keren
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.
Academic Article
Overview
publication date
- September 27, 2022
published in
- Blood advances Journal
Research
keywords
- Immunoglobulin Light-chain Amyloidosis
Identity
PubMed Central ID
- PMC9631711
Scopus Document Identifier
- 85139433950
Digital Object Identifier (DOI)
- 10.1182/bloodadvances.2022007826
PubMed ID
- 35858371
Additional Document Info
volume
- 6
issue
- 18